Literature DB >> 17062763

Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

Marta Cortón1, José I Botella-Carretero, Alberto Benguría, Gemma Villuendas, Angel Zaballos, José L San Millán, Héctor F Escobar-Morreale, Belén Peral.   

Abstract

CONTEXT: The polycystic ovary syndrome (PCOS) is frequently associated with visceral obesity, suggesting that omental adipose tissue might play an important role in the pathogenesis of the syndrome.
OBJECTIVE: The objective was to study the expression profiles of omental fat biopsy samples obtained from morbidly obese women with or without PCOS at the time of bariatric surgery.
DESIGN: This was a case-control study. SETTINGS: We conducted the study in an academic hospital. PATIENTS: Eight PCOS patients and seven nonhyperandrogenic women submitted to bariatric surgery because of morbid obesity.
INTERVENTIONS: Biopsy samples of omental fat were obtained during bariatric surgery. MAIN OUTCOME MEASURE: The main outcome measure was high-density oligonucleotide arrays.
RESULTS: After statistical analysis, we identified changes in the expression patterns of 63 genes between PCOS and control samples. Gene classification was assessed through data mining of Gene Ontology annotations and cluster analysis of dysregulated genes between both groups. These methods highlighted abnormal expression of genes encoding certain components of several biological pathways related to insulin signaling and Wnt signaling, oxidative stress, inflammation, immune function, and lipid metabolism, as well as other genes previously related to PCOS or to the metabolic syndrome.
CONCLUSION: The differences in the gene expression profiles in visceral adipose tissue of PCOS patients compared with nonhyperandrogenic women involve multiple genes related to several biological pathways, suggesting that the involvement of abdominal obesity in the pathogenesis of PCOS is more ample than previously thought and is not restricted to the induction of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062763     DOI: 10.1210/jc.2006-1665

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Affymetrix GeneChip microarray preprocessing for multivariate analyses.

Authors:  Matthew N McCall; Anthony Almudevar
Journal:  Brief Bioinform       Date:  2011-12-30       Impact factor: 11.622

Review 2.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

3.  Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Mediators of Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.

Authors:  Muraly Puttabyatappa; Victoria Andriessen; Makeda Mesquitta; Lixia Zeng; Subramaniam Pennathur; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

Review 4.  A Scoping Review of Artificial Intelligence and Machine Learning in Bariatric and Metabolic Surgery: Current Status and Future Perspectives.

Authors:  Athanasios G Pantelis; Georgios K Stravodimos; Dimitris P Lapatsanis
Journal:  Obes Surg       Date:  2021-07-15       Impact factor: 4.129

5.  Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.

Authors:  Alice Y Chang; Antigoni Z Lalia; Gregory D Jenkins; Tumpa Dutta; Rickey E Carter; Ravinder J Singh; K Sreekumaran Nair
Journal:  Metabolism       Date:  2017-03-08       Impact factor: 8.694

Review 6.  Adipose tissue dysfunction in polycystic ovary syndrome.

Authors:  Jennifer Villa; Richard E Pratley
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

Review 7.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

8.  Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues.

Authors:  Shadia E Nada; Robert C Thompson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

9.  Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.

Authors:  Urmi Sengupta; Sanchaita Ukil; Nevenka Dimitrova; Shipra Agrawal
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

Review 10.  Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.

Authors:  Bulent O Yildiz; Ricardo Azziz
Journal:  Fertil Steril       Date:  2009-04-25       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.